News RSNA 2016: Philips to Debut Advanced Software Applications to Evaluate Neurological Disorders RSNA 2016: Philips to Debut Advanced Software Applications to Evaluate Neurological Disorders by Patricia Silva, PhD | November 22, 2016 Share this article: Share article via email Copy article link Royal PhilipsĀ willĀ introduce a new suite of magnetic resonance (MR)-based software applications at the upcomingĀ Radiological Society of North Americaās 102ndĀ Scientific Meeting and Annual Assembly (RSNA 2016;Ā #RSNA16) Nov. 27 to Dec. 2 in Chicago. Philipsā Ingenia family of digital MRI systemsĀ provides radiologists with a unique set of tools to explore new territories in neurological disorders, including multiple sclerosis (MS), Alzheimerās disease, dementia, and traumatic brain injury. Advanced diagnostics like MRIs are critical in the treatment protocol of neurological diseases. MRIs, for example, are a great way to look at soft tissue, and doctors can retrieve a great deal of structural and physiological information of the brain from these scans. Because of this, MRIs have become a standard tool in neuroimaging, and 65 percent of neurologists prefer MR-based technology over other alternatives. The new Philips portfolio of products uses the companyās dStream digital broadband architecture technology, which digitizes the signal right in the coil, eliminating noise influences to capture the MR signal without pre-distortion or compression. The portfolio includes black blood imaging (a technology that provides high-resolution 3D brain images with reduction of the blood signal); 4D-TRANCE (a noncontrast technique that provides contrast-free dynamic imaging of the brain vascular anatomy); and MultiBand SENSE (a product allowing simultaneous acquisition of multiple slices in the brain for high-resolution, high-speed scans). The new products will be integrated into the latest version of Philipsā IntelliSpace Portal, which will also be unveiled at RSNA 2016. The newest version of the portal is designed to place an additional focus on enhanced depth of clinical analyses in patients with neurological conditions of different complexity levels. āIn a society where neurological disorders impact a large population, continued innovation is critical in improving diagnostic clarity and treatment guidance for all neurological patients,” Eric Jean, Philipsā general manager of MRI, said in a press release. “Our new suite of decision support solutions will empower radiologists with actionable insights to make fast diagnoses to help improve the patient experience and health outcomes overall, while at the same time reducing cost,” he said. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags diagnosis, magnetic resonance imaging, MRI, neurological diseases
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Long-term data support early Kesimpta start in relapsing MS
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8